Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 26, 2012 - Issue 11
253
Views
10
CrossRef citations to date
0
Altmetric
Short Communications

In vitro antiviral activities of extracts derived from Daucus maritimus seeds

, , , , , & show all
Pages 1027-1032 | Received 01 May 2010, Accepted 20 Dec 2010, Published online: 06 Sep 2011
 

Abstract

The antiviral activities of extracts from Daucus maritimus seeds were investigated against the reverse transcriptase of human immunodeficiency virus (HIV) type 1 and a panel of RNA-dependent RNA polymerases of dengue virus, West Nile virus (WNV) and hepatitis C virus (HCV). The extracts showed moderate to potent inhibition rates against the four viral polymerases. The ethyl acetate extract exhibited a potent inhibitory effect against WNV's RdRp, with an IC50 value of 8 µg mL−1. The F 2 fraction exhibited potent inhibitory activity against WNV and HCV's RdRps, with IC50 values 1 and 5 µg mL−1, respectively. The P 2 fraction also showed potent inhibitory effects on WNV and HCV's RdRps, with IC50 values 2.7 and 4 µg mL−1, respectively. The results suggest that these extracts are candidates for the development of new anti-WNV RpDp and anti-HCV RpDp agents.

Acknowledgements

The authors thank Professor M. Chaib (Department of Biology, Faculty of Science, University of Sfax, Tunisia) for the identification of plant.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.